维普期刊资源整合服务平台（V6.5）

34篇 您的检索式：作者名="Conte PF"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Ovarian cancer:optimal chemotherapy in relapsed disease显示文摘	Conte PF Cianci L Tanganelli L	2000	Ann Oncol2000，16，：	1
2	Intraperitoneal chemotherapy in the management of patients with ad-vanced epithelial ovarian cancer:a critical review of the literature显示文摘	Gadducci A Conte PF	2008	Int J Gynecol Cancer2008，18，：	1
3	Conventional versus cytokinetic polychemotherapy with estrogenic recruitment in metastatic breast cancer: results of a randomized cooporative trial显示文摘	Pronzato P Rubagotti A	1987	J Clin Oncol1987，5，3：	1
4	Consolidation and maintenance treatrnents for patients with advanced epithelial ovarian cancer in complete response after first - line chemotherapy:A review of the literature 显示文摘	Gadducci A Conte PF	2005	Crit Rev Oncol Hematol2005，55，1：	1
5	Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase Ⅱ study显示文摘	Gennari A Donati S	2001	Breast Cancer Res Treat2001，68，2：	1
6	Evaluation of the ovarian cancer antigen, CA125 as a tumor marker显示文摘	Onetto M Bruzzone M Conte PF eta\|	1989	Oncology1989，46，4：	1
7	Consolidation and mai-ntenance treatments for patients with advanced epithelial ovariancancer in complete response after first line chemotherapy:areview of the literature显示文摘	Gadducci A Cosio S Conte PF	2005	Crit Rev Oncol Hematol2005，55，2：	1
8	Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer:A Phase Ⅱ study显示文摘	Conte PF Gennari A Donati S	2001	Breast Cancer Res Treat2001，68，2：	1
9	Safety of intravenous and oral bisphosphonates and compliance with dosing regimens显示文摘	Conte PF Guarneri V	2004	Oncologist2004，9，4：	1
10	Consolidation and mainte- nance treatments for patients with advanced epithelial ovarian cancer in complete response after first - line chemotherapy: a review of the literature显示文摘	Gadducci A Cosio S Conte PF	2005	Crit Rev Oncol Hemato12005，55，2：	1
11	Intraperitoneal chemotherapy in the management of patients with advanced epithelial ovarian cancer: a critical review of the literature 显示文摘	Gadducci A Conte PF	2008	Int J Gynecol Cancer2008，18，：	1
12	Consolidation and maintenance treatments for patients with advanced epithelial ovarian cancer in complete response after first-line chemotherapy : a review of the liter- ature 显示文摘	Gadducci A Cosio S Conte PF	2005	Crit Rev Oncol Hemato12005，55，2：	1
13	Dose-flnding study and pharmacokinetics of epirubicin and paclitaxel over 3 hour: A regimen with high activity and low cardiotoxicity in advanced breast cancer显示文摘	Conte PF Baldini E Gennari A	1997	J Clin Onco11997，15，7：	1
14	Concomitant versus sequential administration of epirubicin and paclitaxel as first-line therapy in metastatic breast carcinoma:results for the Group Oncological Northwest Randomized Trial显示文摘	Conte PF Guarneri V Bruzzi P	2004	Cancer2004，101，4：	1
15	The curability of breast cancer and the treatment of advanced disease 显示文摘	Guameri V Conte PF	2004	Eur J Nucl Med Mol Imaging2004，31，：	1
16	Dose-finding study and phar-macokinetics of epiubicin and paclitaxel over 3 hours:A regimen with high activity and low cardiotoxicity in advanced breast cancer显示文摘	Conte PF Baldini E Gennari A	1997	Clin Oncol1997，15，7：	1
17	Delayed progression of bone metastases with pamidronate therapy in breast cancer patients:Arandomized,multicenter phase Ⅲ trial显示文摘	Conte PF Giannessi PG Latreille J	1994	Ann Oncol1994，5，7：	1
18	Evaluation of the ovarian cancer antigen,CA125,and CA50 cytolsolic content in non-small cell lung cancer显示文摘	Picardo AL Bruzzone M Conte PF	1994	Cancer1994，73，：	1
19	Dose-finding study and pharmacokinetics of epirubicin and paclitaxel over 3 hour: a regimen with high activity and low cardiotoxicity in advanced breast cancer显示文摘	Conte PF Baldini E Gennari A	1997	J Clin Oncol1997，15，7：	1
20	Intrap eritoneal chemotherapy in the management of patients with advanced epithelial ovarian cancer: a critical review of theliterature 显示文摘	Gadducci A Conte PF	2008	Int J Gynecol Cancer2008，10，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示